Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7077-7086
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7077
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7077
Table 1 Indications and contraindications of radiofrequency ablation for hepatic hemangiomas
| Indications |
| The maximum diameter of hemangiomas > 5 cm |
| Tumor gaining an enlargement of more than 1 cm within 2 yr |
| Persistent hemangioma-related abdominal pain or discomfort |
| Consent to receive the RF ablation |
| Contraindications |
| Severe bleeding tendency, platelets < 50 × 109/L, international normalized ratio > 1.5, severe platelet function disorders (prothrombin time >18 s and prothrombin activity < 40%) |
| Malignant tumors |
| Kasabach-Merritt syndrome |
| Infection, especially biliary system inflammation |
| Low immune function |
| Severe primary organ failure such as the liver, kidney, heart, lung and/or brain |
- Citation: Gao J, Fan RF, Yang JY, Cui Y, Ji JS, Ma KS, Li XL, Zhang L, Xu CL, Kong XL, Ke S, Ding XM, Wang SH, Yang MM, Song JJ, Zhai B, Nin CM, Guo SG, Xin ZH, Lu J, Dong YH, Zhu HQ, Sun WB. Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts. World J Gastroenterol 2017; 23(39): 7077-7086
- URL: https://www.wjgnet.com/1007-9327/full/v23/i39/7077.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i39.7077